0.012341 0.007125 0.000000 0.000000 0.014250 0.000000 0.000000 0.000000 0.029499 0.00000 0.00000 0.00000 Wagner, A. Diez, J. Schulze-Briese, C. Schluckebier, G. http://mmcif.pdb.org/dictionaries/ascii/mmcif_pdbx.dic 18 90.00 90.00 120.00 81.030 81.030 33.900 C3 H7 N O2 89.093 y ALANINE L-peptide linking C6 H15 N4 O2 1 175.209 y ARGININE L-peptide linking C4 H8 N2 O3 132.118 y ASPARAGINE L-peptide linking C3 H7 N O2 S 121.158 y CYSTEINE L-peptide linking C5 H10 N2 O3 146.144 y GLUTAMINE L-peptide linking C5 H9 N O4 147.129 y GLUTAMIC ACID L-peptide linking C2 H5 N O2 75.067 y GLYCINE peptide linking C6 H10 N3 O2 1 156.162 y HISTIDINE L-peptide linking H2 O 18.015 WATER non-polymer C6 H13 N O2 131.173 y ISOLEUCINE L-peptide linking C6 H13 N O2 131.173 y LEUCINE L-peptide linking C6 H15 N2 O2 1 147.195 y LYSINE L-peptide linking C8 H8 O3 152.147 4-HYDROXY-BENZOIC ACID METHYL ESTER non-polymer C9 H11 N O2 165.189 y PHENYLALANINE L-peptide linking C5 H9 N O2 115.130 y PROLINE L-peptide linking C3 H7 N O3 105.093 y SERINE L-peptide linking C4 H9 N O3 119.119 y THREONINE L-peptide linking C9 H11 N O3 181.189 y TYROSINE L-peptide linking C5 H11 N O2 117.146 y VALINE L-peptide linking Zn 2 65.409 ZINC ION non-polymer US Proteins PSFGEY 0867 0887-3585 74 1018 10.1002/PROT.22213 18767151 Crystal Structure of Ultralente--A Microcrystalline Insulin Suspension. 2009 1.000000 0.000000 0.000000 0.000000 1.000000 0.000000 0.000000 0.000000 1.000000 0.00000 0.00000 0.00000 100 1 MICRO FOCUS CCD MARRESEARCH SINGLE WAVELENGTH M x-ray 1 0.9786 1.0 X06SA SLS 0.9786 SYNCHROTRON SLS BEAMLINE X06SA ULTRALENTE INSULIN CRYSTALS 2383.698 INSULIN A CHAIN RESIDUES 90-110 2 man polymer ULTRALENTE INSULIN CRYSTALS 3433.953 INSULIN B CHAIN RESIDUES 25-54 2 man polymer 65.409 ZINC ION 4 syn non-polymer 152.147 4-HYDROXY-BENZOIC ACID METHYL ESTER 1 syn non-polymer 18.015 water 66 nat water no no GIVEQCCTSICSLYQLENYCN GIVEQCCTSICSLYQLENYCN A,C polypeptide(L) no no FVNQHLCGSHLVEALYLVCGERGFFYTPKT FVNQHLCGSHLVEALYLVCGERGFFYTPKT B,D polypeptide(L) n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n HUMAN sample 9606 HOMO SAPIENS 4932 SACCHAROMYCES CEREVISIAE HUMAN sample 9606 HOMO SAPIENS 4932 SACCHAROMYCES CEREVISIAE 1 1.78 30.48 DATA COLLECTION FROM MICRO CRYSTAL 25-X-25 X 8 MICROMETER 5.5 pH 5.5 repository Initial release Advisory Version format compliance Database references Derived calculations Other 1 0 2008-09-16 1 1 2011-07-13 1 2 2011-08-03 R6 HUMAN INSULIN HEXAMER (NON-SYMMETRIC), NMR, 10 STRUCTURES R6 HUMAN INSULIN HEXAMER (SYMMETRIC), NMR, 10 STRUCTURES INSULIN COMPLEXED WITH 4-HYDROXYBENZAMIDE STRUCTURE OF THE RHOMBOHEDRAL FORM OF THE M-CRESOL/INSULIN R6 HEXAMER STRUCTURE OF THE MONOCLINIC FORM OF THE M -CRESOL/INSULIN R6 HEXAMER 1.3 A STRUCTURE OF T3R3 HUMAN INSULIN AT 100 K INSULIN (HUMAN) MUTANT WITH PHE B 24 REPLACED BY SER (F24S) (NMR, REPRESENTATIVE PLUS 9 STRUCTURES) INSULIN (HUMAN) MUTANT WITH PHE B 24 REPLACED BY GLY (F24G) (NMR, REPRESENTATIVE PLUS 8 STRUCTURES) NMR STRUCTURE OF THE HUMAN INSULIN-HIS(B16) CRYSTAL STRUCTURE OF DESTRIPEPTIDE (B28-B30) INSULIN INSULIN MUTANT (B1, B10, B16, B27)GLU, DES -B30, NMR, 25 STRUCTURES INSULIN MUTANT A8 HIS,(B1, B10, B16, B27) GLU, DES-B30, NMR, 26 STRUCTURES CRYSTAL STRUCTURE OF AN UNSTABLE INSULIN ANALOG WITH NATIVEACTIVITY. SOLUTION STRUCTURE OF THE MONOMERIC [THR(B27 )->PRO,PRO(B28)->THR] INSULIN MUTANT (PT INSULIN) NMR STRUCTURE OF HUMAN INSULIN MUTANT ILE- A2-GLY, VAL-A3-GLY, HIS-B10-ASP, PRO- B28-LYS, LYS-B29-PRO, 20 STRUCTURES MOL_ID: 1; MOLECULE: INSULIN; CHAIN: A, B; ENGINEERED: YES MUTATION: S(B 9)D; T6 HUMAN INSULIN AT 1.0 A RESOLUTION DEHYDRATED T6 HUMAN INSULIN AT 295 K CRYSTAL STRUCTURE OF ALLO-ILEA2-INSULIN, AN INACTIVE CHIRALANALOGUE: IMPLICATIONS FOR THE MECHANISM OF RECEPTOR HUMAN INSULIN HEXAMERS WITH CHAIN B HIS MUTATED TO TYR COMPLEXED WITH RESORCINOL HUMAN INSULIN HEXAMERS WITH CHAIN B HIS MUTATED TO TYR INSULIN (T3R3) (PH 5.6, 1.0 M NACL) COMPLEXED WITH TWO ZINC IONS AND TYLENOL ( 4'-HYDROXYACETANILIDE) HUMAN INSULIN TWO DISULFIDE MODEL, NMR, 10 STRUCTURES STRUCTURAL PROPERTIES OF THE B25TYR-NME- B26PHE INSULIN MUTANT. STRUCTURE OF INSULIN INSULIN, MONOCLINIC CRYSTAL FORM INSULIN MUTANT B16 GLU, B24 GLY, DES-B30 , NMR, 20 STRUCTURES HUMAN INSULIN MUTANT SERB9GLU AN ACTIVE MINI-PROINSULIN, M2PI THE STRUCTURE OF THE RESORCINOL/INSULIN R6 HEXAMER FIRST PROTEIN STRUCTURE DETERMINED FROM X- RAY POWDERDIFFRACTION DATA FIRST PROTEIN STRUCTURE DETERMINED FROM X- RAY POWDERDIFFRACTION DATA 1.2 A STRUCTURE OF T3R3 HUMAN INSULIN AT 100 K INSULIN AT PH 2: STRUCTURAL ANALYSIS OF THE CONDITIONS PROMOTING INSULIN FIBRE FORMATION. INSULIN (HUMAN, DES-PENTAPEPTIDE (B 26 - B 30)) (NMR, REPRESENTATIVE PLUS 14 STRUCTURES) INSULIN MUTANT A3 GLY,(B1, B10, B16, B27) GLU, DES-B30, NMR, 19 STRUCTURES NON-STANDARD DESIGN OF UNSTABLE INSULIN ANALOGUES WITHENHANCED ACTIVITY NMR STRUCTURE OF HUMAN INSULIN MUTANT ILE- A2-ALA, HIS-B10-ASP, PRO-B28-LYS, LYS- B29-PRO, 15 STRUCTURES NMR STRUCTURE OF HUMAN INSULIN MUTANT ILE- A2-ALLO-ILE, HIS-B10-ASP, PRO-B28-LYS, LYS-B29-PRO, 15 STRUCTURES LYS(B28)PRO(B29)-HUMAN INSULIN MOL_ID: 1; MOLECULE: INSULIN; CHAIN: A, B; ENGINEERED: YES MUTATION: DES-[PHE(B 25)]; DEHYDRATED T6 HUMAN INSULIN AT 100 K HUMAN INSULIN HEXAMERS WITH CHAIN B HIS MUTATED TO TYR COMPLEXED WITH PHENOL ENHANCING THE ACTIVITY OF INSULIN AT RECEPTOR EDGE: CRYSTALSTRUCTURE AND PHOTO- CROSS-LINKING OF A8 ANALOGUES NMR STRUCTURE OF HUMAN INSULIN UNDER AMYLOIDOGENICCONDITION, 15 STRUCTURES MINI-PROINSULIN, TWO CHAIN INSULIN ANALOG MUTANT: DES B30, HIS(B 10)ASP, PRO(B 28)ASP, NMR, 20 STRUCTURES SOLUTION STRUCTURE OF HUMAN PROINSULIN C- PEPTIDE NMR STRUCTURE OF HUMAN INSULIN MUTANT HIS- B10-ASP, VAL-B12-ALA, PRO-B28-LYS, LYS- B29-PRO, 15 STRUCTURES NMR STRUCTURE OF HUMAN INSULIN MUTANT HIS- B10-ASP, VAL-B12-THR, PRO-B28-LYS, LYS- B29-PRO, 15 STRUCTURES DESPENTAPEPTIDE INSULIN IN ACETIC ACID (PH 2) NMR STRUCTURE OF HUMAN INSULIN IN 20% ACETIC ACID, ZINC-FREE, 10 STRUCTURES R6 HUMAN INSULIN HEXAMER (SYMMETRIC), NMR, REFINED AVERAGE STRUCTURE R6 HUMAN INSULIN HEXAMER (SYMMETRIC), NMR, ' GREEN' SUBSTATE, AVERAGE STRUCTURE R6 HUMAN INSULIN HEXAMER (SYMMETRIC), NMR, ' RED' SUBSTATE, AVERAGE STRUCTURE NMR STRUCTURE OF HUMAN INSULIN MUTANT HIS- B10-ASP, VAL-B12-ABA, PRO-B28-LYS, LYS- B29-PRO, 15 STRUCTURES INSULIN (T3R3) COMPLEX WITH TWO ZINC IONS INSULIN (T3R3) (PH 6.4, 0.75 M NACL) COMPLEXED WITH TWO ZINC IONS AND TYLENOL ( 4'-HYDROXYACETANILIDE) CRYSTALLOGRAPHIC AND SOLUTION STUDIES OF N- LITHOCHOLYL INSULIN: A NEW GENERATION OF PROLONGED-ACTING INSULINS. HUMAN INSULIN DISULFIDE ISOMER, NMR, 10 STRUCTURES DIABETES-ASSOCIATED MUTATIONS IN HUMAN INSULIN : CRYSTALSTRUCTURE AND PHOTO-CROSS-LINKING STUDIES OF A-CHAINVARIANT INSULIN WAKAYAMA STRUCTURE OF B28 ASP INSULIN IN COMPLEX WITH PHENOL STRUCTURE OF INSULIN R6 HUMAN INSULIN HEXAMER (SYMMETRIC), NMR, 20 STRUCTURES INSULINE(1SEC) AND UV LASER EXCITED FLUORESCENCE INSULINE(60SEC) AND UV LASER EXCITED FLUORESCENCE NMR STRUCTURE OF HUMAN INSULIN MUTANT HIS- B5-ALA, HIS-B10-ASP PRO-B28-LYS, LYS- B29-PRO, 20 STRUCTURES NMR STRUCTURE OF HUMAN INSULIN MUTANT GLY- B8-D-SER, HIS-B10-ASP PRO-B28-LYS, LYS -B29-PRO, 20 STRUCTURES NMR STRUCTURE OF HUMAN INSULIN MUTANT GLY- B8-SER, HIS-B10-ASP PRO-B28-LYS, LYS- B29-PRO, 20 STRUCTURES CRYSTAL STRUCTURE FORM ULTALENTE INSULIN MICROCRYSTALS PDBE Y PDBE 2007-12-14 REL ZN ZINC ION MPB 4-HYDROXY-BENZOIC ACID METHYL ESTER HOH water ZN 1031 3 ZN ZN 1031 B MPB 1022 4 MPB MPB 1022 C ZN 1030 3 ZN ZN 1030 D ZN 1031 3 ZN ZN 1031 D ZN 1032 3 ZN ZN 1032 D HOH 2001 5 HOH HOH 2001 A HOH 2002 5 HOH HOH 2002 A HOH 2003 5 HOH HOH 2003 A HOH 2004 5 HOH HOH 2004 A HOH 2005 5 HOH HOH 2005 A HOH 2006 5 HOH HOH 2006 A HOH 2007 5 HOH HOH 2007 A HOH 2008 5 HOH HOH 2008 A HOH 2009 5 HOH HOH 2009 A HOH 2010 5 HOH HOH 2010 A HOH 2011 5 HOH HOH 2011 A HOH 2012 5 HOH HOH 2012 A HOH 2013 5 HOH HOH 2013 A HOH 2014 5 HOH HOH 2014 A HOH 2015 5 HOH HOH 2015 A HOH 2001 5 HOH HOH 2001 B HOH 2002 5 HOH HOH 2002 B HOH 2003 5 HOH HOH 2003 B HOH 2004 5 HOH HOH 2004 B HOH 2005 5 HOH HOH 2005 B HOH 2006 5 HOH HOH 2006 B HOH 2007 5 HOH HOH 2007 B HOH 2008 5 HOH HOH 2008 B HOH 2009 5 HOH HOH 2009 B HOH 2010 5 HOH HOH 2010 B HOH 2011 5 HOH HOH 2011 B HOH 2012 5 HOH HOH 2012 B HOH 2013 5 HOH HOH 2013 B HOH 2014 5 HOH HOH 2014 B HOH 2015 5 HOH HOH 2015 B HOH 2016 5 HOH HOH 2016 B HOH 2017 5 HOH HOH 2017 B HOH 2018 5 HOH HOH 2018 B HOH 2019 5 HOH HOH 2019 B HOH 2020 5 HOH HOH 2020 B HOH 2021 5 HOH HOH 2021 B HOH 2022 5 HOH HOH 2022 B HOH 2023 5 HOH HOH 2023 B HOH 2024 5 HOH HOH 2024 B HOH 2025 5 HOH HOH 2025 B HOH 2001 5 HOH HOH 2001 C HOH 2002 5 HOH HOH 2002 C HOH 2003 5 HOH HOH 2003 C HOH 2004 5 HOH HOH 2004 C HOH 2005 5 HOH HOH 2005 C HOH 2006 5 HOH HOH 2006 C HOH 2007 5 HOH HOH 2007 C HOH 2008 5 HOH HOH 2008 C HOH 2009 5 HOH HOH 2009 C HOH 2001 5 HOH HOH 2001 D HOH 2002 5 HOH HOH 2002 D HOH 2003 5 HOH HOH 2003 D HOH 2004 5 HOH HOH 2004 D HOH 2005 5 HOH HOH 2005 D HOH 2006 5 HOH HOH 2006 D HOH 2007 5 HOH HOH 2007 D HOH 2008 5 HOH HOH 2008 D HOH 2009 5 HOH HOH 2009 D HOH 2010 5 HOH HOH 2010 D HOH 2011 5 HOH HOH 2011 D HOH 2012 5 HOH HOH 2012 D HOH 2013 5 HOH HOH 2013 D HOH 2014 5 HOH HOH 2014 D HOH 2015 5 HOH HOH 2015 D HOH 2016 5 HOH HOH 2016 D HOH 2017 5 HOH HOH 2017 D GLY 1 n 1 GLY 1 A ILE 2 n 2 ILE 2 A VAL 3 n 3 VAL 3 A GLU 4 n 4 GLU 4 A GLN 5 n 5 GLN 5 A CYS 6 n 6 CYS 6 A CYS 7 n 7 CYS 7 A THR 8 n 8 THR 8 A SER 9 n 9 SER 9 A ILE 10 n 10 ILE 10 A CYS 11 n 11 CYS 11 A SER 12 n 12 SER 12 A LEU 13 n 13 LEU 13 A TYR 14 n 14 TYR 14 A GLN 15 n 15 GLN 15 A LEU 16 n 16 LEU 16 A GLU 17 n 17 GLU 17 A ASN 18 n 18 ASN 18 A TYR 19 n 19 TYR 19 A CYS 20 n 20 CYS 20 A ASN 21 n 21 ASN 21 A n 1 1 B n 2 2 B ASN 3 n 3 ASN 3 B GLN 4 n 4 GLN 4 B HIS 5 n 5 HIS 5 B LEU 6 n 6 LEU 6 B CYS 7 n 7 CYS 7 B GLY 8 n 8 GLY 8 B SER 9 n 9 SER 9 B HIS 10 n 10 HIS 10 B LEU 11 n 11 LEU 11 B VAL 12 n 12 VAL 12 B GLU 13 n 13 GLU 13 B ALA 14 n 14 ALA 14 B LEU 15 n 15 LEU 15 B TYR 16 n 16 TYR 16 B LEU 17 n 17 LEU 17 B VAL 18 n 18 VAL 18 B CYS 19 n 19 CYS 19 B GLY 20 n 20 GLY 20 B GLU 21 n 21 GLU 21 B ARG 22 n 22 ARG 22 B GLY 23 n 23 GLY 23 B PHE 24 n 24 PHE 24 B PHE 25 n 25 PHE 25 B TYR 26 n 26 TYR 26 B THR 27 n 27 THR 27 B PRO 28 n 28 PRO 28 B LYS 29 n 29 LYS 29 B THR 30 n 30 THR 30 B GLY 1 n 1 GLY 1 C ILE 2 n 2 ILE 2 C VAL 3 n 3 VAL 3 C GLU 4 n 4 GLU 4 C GLN 5 n 5 GLN 5 C CYS 6 n 6 CYS 6 C CYS 7 n 7 CYS 7 C THR 8 n 8 THR 8 C SER 9 n 9 SER 9 C ILE 10 n 10 ILE 10 C CYS 11 n 11 CYS 11 C SER 12 n 12 SER 12 C LEU 13 n 13 LEU 13 C TYR 14 n 14 TYR 14 C GLN 15 n 15 GLN 15 C LEU 16 n 16 LEU 16 C GLU 17 n 17 GLU 17 C ASN 18 n 18 ASN 18 C TYR 19 n 19 TYR 19 C CYS 20 n 20 CYS 20 C ASN 21 n 21 ASN 21 C n 1 1 D n 2 2 D ASN 3 n 3 ASN 3 D GLN 4 n 4 GLN 4 D HIS 5 n 5 HIS 5 D LEU 6 n 6 LEU 6 D CYS 7 n 7 CYS 7 D GLY 8 n 8 GLY 8 D SER 9 n 9 SER 9 D HIS 10 n 10 HIS 10 D LEU 11 n 11 LEU 11 D VAL 12 n 12 VAL 12 D GLU 13 n 13 GLU 13 D ALA 14 n 14 ALA 14 D LEU 15 n 15 LEU 15 D TYR 16 n 16 TYR 16 D LEU 17 n 17 LEU 17 D VAL 18 n 18 VAL 18 D CYS 19 n 19 CYS 19 D GLY 20 n 20 GLY 20 D GLU 21 n 21 GLU 21 D ARG 22 n 22 ARG 22 D GLY 23 n 23 GLY 23 D PHE 24 n 24 PHE 24 D PHE 25 n 25 PHE 25 D TYR 26 n 26 TYR 26 D THR 27 n 27 THR 27 D PRO 28 n 28 PRO 28 D LYS 29 n 29 LYS 29 D n 30 30 D 3.3724 -2.7982 1.4970 25.0566 -4.5299 6.8672 0.3050 -0.1631 0.2121 1.9059 -0.4780 0.7190 0.2207 -0.0797 0.1731 0.0522 -0.0289 0.0969 0.1002 -0.0699 -0.0243 refined -17.5527 3.2261 7.1512 X-RAY DIFFRACTION 6.5864 -1.7917 1.0440 14.7851 -0.8415 7.5693 -0.0384 -0.2890 0.0013 0.7324 -0.0442 -0.4818 -0.0390 -0.5311 0.0825 -0.0142 0.0016 0.0170 -0.1000 0.0266 -0.0106 refined -12.2215 5.5002 2.1411 X-RAY DIFFRACTION 13.1219 -0.2588 -1.3341 2.3696 1.2019 3.4586 -0.2833 1.0346 -0.2392 -0.7944 0.2331 0.5489 -0.1054 -0.4397 0.0502 0.2819 -0.0760 -0.0230 0.0235 0.0557 0.0391 refined -3.4775 16.7617 -9.1115 X-RAY DIFFRACTION 10.3195 -0.9008 0.9903 6.9885 2.4961 5.6334 0.0413 0.4760 0.0896 -0.4038 0.0393 0.0799 -0.1596 -0.1436 -0.0805 -0.0097 -0.0237 0.0485 -0.0864 0.0612 -0.0645 refined -5.3243 11.0453 -4.3057 X-RAY DIFFRACTION A 1 A 21 X-RAY DIFFRACTION 1 B 1 B 30 X-RAY DIFFRACTION 2 C 1 C 21 X-RAY DIFFRACTION 3 D 1 D 30 X-RAY DIFFRACTION 4 author_and_software_defined_assembly PISA 12 dodecameric 18950 -568.0 12600 B HIS 10 B NE2 HIS 10 2_555 B ZN 1031 E ZN ZN 1_555 B HIS 10 B NE2 HIS 10 1_555 113.0 B HIS 10 B NE2 HIS 10 2_555 B ZN 1031 E ZN ZN 1_555 B HIS 10 B NE2 HIS 10 3_555 113.0 B HIS 10 B NE2 HIS 10 1_555 B ZN 1031 E ZN ZN 1_555 B HIS 10 B NE2 HIS 10 3_555 113.0 B HIS 10 B NE2 HIS 10 2_555 B ZN 1031 E ZN ZN 1_555 B HOH 2025 K O HOH 1_555 105.6 B HIS 10 B NE2 HIS 10 1_555 B ZN 1031 E ZN ZN 1_555 B HOH 2025 K O HOH 1_555 105.6 B HIS 10 B NE2 HIS 10 3_555 B ZN 1031 E ZN ZN 1_555 B HOH 2025 K O HOH 1_555 105.6 B HIS 10 B NE2 HIS 10 2_555 B ZN 1031 E ZN ZN 1_555 B HOH 2025 K O HOH 2_555 105.6 B HIS 10 B NE2 HIS 10 1_555 B ZN 1031 E ZN ZN 1_555 B HOH 2025 K O HOH 2_555 105.6 B HIS 10 B NE2 HIS 10 3_555 B ZN 1031 E ZN ZN 1_555 B HOH 2025 K O HOH 2_555 105.6 B HOH 2025 K O HOH 1_555 B ZN 1031 E ZN ZN 1_555 B HOH 2025 K O HOH 2_555 0.0 B HIS 10 B NE2 HIS 10 2_555 B ZN 1031 E ZN ZN 1_555 B HOH 2025 K O HOH 3_555 105.6 B HIS 10 B NE2 HIS 10 1_555 B ZN 1031 E ZN ZN 1_555 B HOH 2025 K O HOH 3_555 105.6 B HIS 10 B NE2 HIS 10 3_555 B ZN 1031 E ZN ZN 1_555 B HOH 2025 K O HOH 3_555 105.6 B HOH 2025 K O HOH 1_555 B ZN 1031 E ZN ZN 1_555 B HOH 2025 K O HOH 3_555 0.0 B HOH 2025 K O HOH 2_555 B ZN 1031 E ZN ZN 1_555 B HOH 2025 K O HOH 3_555 0.0 D HIS 10 D NE2 HIS 10 1_555 D ZN 1030 G ZN ZN 1_555 D HIS 10 D NE2 HIS 10 2_555 108.4 D HIS 10 D NE2 HIS 10 1_555 D ZN 1030 G ZN ZN 1_555 D HIS 10 D NE2 HIS 10 3_555 108.4 D HIS 10 D NE2 HIS 10 2_555 D ZN 1030 G ZN ZN 1_555 D HIS 10 D NE2 HIS 10 3_555 108.4 D GLU 13 D OE1 GLU 13 1_555 D ZN 1031 H ZN ZN 1_555 D HOH 2017 M O HOH 1_555 96.6 D GLU 13 D OE1 GLU 13 1_555 D ZN 1031 H ZN ZN 1_555 D HOH 2016 M O HOH 1_555 87.2 D HOH 2017 M O HOH 1_555 D ZN 1031 H ZN ZN 1_555 D HOH 2016 M O HOH 1_555 135.4 D GLU 13 D OE1 GLU 13 1_555 D ZN 1031 H ZN ZN 1_555 D HIS 10 D ND1 HIS 10 1_555 116.0 D HOH 2017 M O HOH 1_555 D ZN 1031 H ZN ZN 1_555 D HIS 10 D ND1 HIS 10 1_555 121.2 D HOH 2016 M O HOH 1_555 D ZN 1031 H ZN ZN 1_555 D HIS 10 D ND1 HIS 10 1_555 95.8 D HOH 2017 M O HOH 1_555 D ZN 1032 I ZN ZN 1_555 D GLU 13 D OE2 GLU 13 1_555 117.4 1.0000000000 0.0000000000 0.0000000000 0.0000000000 1.0000000000 0.0000000000 0.0000000000 0.0000000000 1.0000000000 1_555 x,y,z identity operation 0.0000000000 0.0000000000 0.0000000000 -0.5000000000 -0.8660254038 0.0000000000 0.8660254038 -0.5000000000 0.0000000000 0.0000000000 0.0000000000 1.0000000000 2_555 -y,x-y,z crystal symmetry operation 0.0000000000 0.0000000000 0.0000000000 -0.5000000000 0.8660254038 0.0000000000 -0.8660254038 -0.5000000000 0.0000000000 0.0000000000 0.0000000000 1.0000000000 3_555 -x+y,-x,z crystal symmetry operation 0.0000000000 0.0000000000 0.0000000000 B N TYR 26 B N TYR 26 D O PHE 24 D O PHE 24 1 B ZN 1031 E ZN 1 D ZN 1030 G ZN 1 B HOH 2025 K HOH 1 D HOH 2003 M HOH 1 B PHE 1 B PHE 1 1 Y 1 B VAL 2 B VAL 2 1 Y 1 D PHE 1 D PHE 1 1 Y 1 D VAL 2 D VAL 2 1 Y 1 D THR 30 D THR 30 1 Y 1 C SER 9 -142.23 -159.83 1 D GLN 4 -136.78 -131.54 1 D HIS 5 -127.23 -107.40 18.75 0.08000 0.04000 0.00000 0.08000 0.00000 -0.13000 0.908 0.865 HYDROGENS HAVE BEEN ADDED IN THE RIDING POSITIONS. 0.282 0.240 0.242 2.20 40.52 209 3958 5.000 98.8 19.805 0.267 RANDOM LIKELY RESIDUAL 1 THROUGHOUT MOLECULAR REPLACEMENT 0.653 0.293 0.80 0.80 1.20 PDB ENTRY MSO MAXIMUM LIKELIHOOD MASK 2.20 40.52 66 847 15 0 766 0.006 0.021 805 0.004 0.020 520 0.970 1.985 1087 1.034 3.019 1248 5.350 5.000 91 37.341 24.865 37 17.823 15.000 124 8.774 15.000 2 0.317 0.200 115 0.002 0.020 888 0.001 0.020 166 0.158 0.200 207 0.176 0.200 525 0.181 0.200 381 0.086 0.200 399 0.106 0.200 34 0.147 0.200 20 0.092 0.200 15 0.066 0.200 7 0.164 1.500 631 0.189 2.000 764 0.272 3.000 419 0.373 4.500 323 0.3700 0.3160 2.26 15 300 20 2.20 24.10 2VK0 13231 0.0 0.07 1 11.80 3.3 98.8 0.21 2.20 2.30 5.70 1 3.2 98.7 refinement REFMAC 5.3.0040 data reduction XDS data scaling XSCALE phasing AMoRE INSULIN A CHAIN, INSULIN B CHAIN Crystal structure form ultalente insulin microcrystals 1 N N 2 N N 1 N N 2 N N 3 N N 4 N N 3 N N 3 N N 3 N N 5 N N 5 N N 5 N N 5 N N A GLY 1 A GLY 1 HELX_P A CYS 7 A CYS 7 1 1 7 A SER 12 A SER 12 HELX_P A GLU 17 A GLU 17 1 2 6 B CYS 7 B CYS 7 HELX_P B GLY 20 B GLY 20 1 3 14 B GLU 21 B GLU 21 HELX_P B GLY 23 B GLY 23 5 4 3 C GLY 1 C GLY 1 HELX_P C SER 9 C SER 9 1 5 9 C SER 12 C SER 12 HELX_P C GLU 17 C GLU 17 1 6 6 D GLY 8 D GLY 8 HELX_P D GLY 20 D GLY 20 1 7 13 D GLU 21 D GLU 21 HELX_P D GLY 23 D GLY 23 5 8 3 disulf 2.031 A CYS 6 A SG CYS 6 1_555 A CYS 11 A SG CYS 11 1_555 disulf 2.031 A CYS 7 A SG CYS 7 1_555 B CYS 7 B SG CYS 7 1_555 disulf 2.033 A CYS 20 A SG CYS 20 1_555 B CYS 19 B SG CYS 19 1_555 disulf 2.028 C CYS 6 C SG CYS 6 1_555 C CYS 11 C SG CYS 11 1_555 disulf 2.034 C CYS 7 C SG CYS 7 1_555 D CYS 7 D SG CYS 7 1_555 disulf 2.031 C CYS 20 C SG CYS 20 1_555 D CYS 19 D SG CYS 19 1_555 metalc 1.987 B ZN 1031 E ZN ZN 1_555 B HIS 10 B NE2 HIS 10 2_555 metalc 1.987 B ZN 1031 E ZN ZN 1_555 B HIS 10 B NE2 HIS 10 1_555 metalc 1.987 B ZN 1031 E ZN ZN 1_555 B HIS 10 B NE2 HIS 10 3_555 metalc 1.899 B ZN 1031 E ZN ZN 1_555 B HOH 2025 K O HOH 1_555 metalc 1.899 B ZN 1031 E ZN ZN 1_555 B HOH 2025 K O HOH 2_555 metalc 1.899 B ZN 1031 E ZN ZN 1_555 B HOH 2025 K O HOH 3_555 metalc 2.016 D ZN 1030 G ZN ZN 1_555 D HIS 10 D NE2 HIS 10 1_555 metalc 2.016 D ZN 1030 G ZN ZN 1_555 D HIS 10 D NE2 HIS 10 2_555 metalc 2.016 D ZN 1030 G ZN ZN 1_555 D HIS 10 D NE2 HIS 10 3_555 metalc 1.941 D ZN 1031 H ZN ZN 1_555 D GLU 13 D OE1 GLU 13 1_555 metalc 2.138 D ZN 1031 H ZN ZN 1_555 D HOH 2017 M O HOH 1_555 metalc 2.006 D ZN 1031 H ZN ZN 1_555 D HOH 2016 M O HOH 1_555 metalc 2.498 D ZN 1031 H ZN ZN 1_555 D HIS 10 D ND1 HIS 10 1_555 metalc 1.989 D ZN 1032 I ZN ZN 1_555 D HOH 2017 M O HOH 1_555 metalc 2.248 D ZN 1032 I ZN ZN 1_555 D GLU 13 D OE2 GLU 13 1_555 HORMONE CARBOHYDRATE METABOLISM, GLUCOSE METABOLISM, MICRO FOCUS BEAMLINE, INSULIN, HORMONE, SECRETED, MICRO CRYSTAL, CLEAVAGE ON PAIR OF BASIC RESIDUES, DISEASE MUTATION, DIABETES MELLITUS INS_HUMAN UNP 1 P01308 INS_HUMAN UNP 2 P01308 90 110 2VK0 1 21 P01308 A 1 1 21 25 54 2VK0 1 30 P01308 B 2 1 30 90 110 2VK0 1 21 P01308 C 1 1 21 25 54 2VK0 1 30 P01308 D 2 1 30 2 anti-parallel B PHE 24 B PHE 24 B TYR 26 B TYR 26 D PHE 24 D PHE 24 D TYR 26 D TYR 26 BINDING SITE FOR RESIDUE ZN D 1030 Software 3 BINDING SITE FOR RESIDUE ZN B 1031 Software 6 BINDING SITE FOR RESIDUE ZN D 1031 Software 7 BINDING SITE FOR RESIDUE ZN D 1032 Software 5 BINDING SITE FOR RESIDUE MPB C 1022 Software 7 D HIS 10 D HIS 10 3 2_555 D HIS 10 D HIS 10 3 1_555 D HIS 10 D HIS 10 3 3_555 B HIS 10 B HIS 10 6 2_555 B HIS 10 B HIS 10 6 1_555 B HIS 10 B HIS 10 6 3_555 B HOH 2025 K HOH 6 2_555 B HOH 2025 K HOH 6 3_555 B HOH 2025 K HOH 6 1_555 B GLU 13 B GLU 13 7 3_555 D SER 9 D SER 9 7 3_555 D HIS 10 D HIS 10 7 1_555 D GLU 13 D GLU 13 7 1_555 D ZN 1032 I ZN 7 1_555 D HOH 2016 M HOH 7 1_555 D HOH 2017 M HOH 7 1_555 B GLU 13 B GLU 13 5 3_555 D GLU 13 D GLU 13 5 3_555 D GLU 13 D GLU 13 5 1_555 D ZN 1031 H ZN 5 1_555 D HOH 2017 M HOH 5 1_555 A LEU 13 A LEU 13 7 3_555 A TYR 14 A TYR 14 7 3_555 A GLU 17 A GLU 17 7 3_555 B VAL 18 B VAL 18 7 3_555 C TYR 14 C TYR 14 7 1_555 C GLU 17 C GLU 17 7 1_555 D VAL 18 D VAL 18 7 1_555 146 H 3